Back
Enfusion Quote, Financials, Valuation and Earnings
Sponsored
ENFN
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
72
ENFN
Enfusion
Last Price:
$10.64
Seasonality Move:
-3.43%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Enfusion Price Quote
$10.64
+0.01 (+1.62%)
(Updated: December 21, 2024 at 5:24 AM ET)
Enfusion Key Stats
Buy
72
Enfusion (ENFN)
is a Buy
Day range:
$10.22 - $10.74
52-week range:
$7.52 - $11.38
Dividend yield:
0%
P/E ratio:
151.86
P/S ratio:
6.47
P/B ratio:
14.35%
Volume:
935.2K
Avg. volume:
519.8K
1-year change:
10.16%
Market cap:
$1B
Revenue:
$174.5M
EPS:
$0.04
How Much Does Enfusion Make?
Data Unavailable
Is Enfusion Growing As A Company?
Data Unavailable
Enfusion Stock Price Performance
What Is Enfusion 52-Week High & Low?
Enfusion Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Enfusion?
Data Unavailable
Is Enfusion Cash Flow Positive?
Data Unavailable
Enfusion Return On Invested Capital
Data Unavailable
Enfusion Earnings Date & Stock Price
-
What Is Enfusion's Stock Price Today?A single share of ENFN can be purchased today for 10.63
-
What Is Enfusion’s Stock Symbol?
-
When Is Enfusion’s Next Earnings Date?The next quarterly earnings date for Enfusion is scheduled on March 12, 2025
-
When Is ENFN's next ex-dividend date?Enfusion's next ex-dividend date is December 22, 2024
-
How To Buy Enfusion Stock?You can buy Enfusion shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Enfusion Competitors
Enfusion Dividend Yield
Data Unavailable
Enfusion Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -11.88% |
Revenue: | 15.35% | -1.92% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable